Literature DB >> 15883319

A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease.

J J Zarranz1, I Ferrer, E Lezcano, M I Forcadas, B Eizaguirre, B Atarés, B Puig, J C Gómez-Esteban, C Fernández-Maiztegui, I Rouco, T Pérez-Concha, M Fernández, O Rodríguez, A B Rodríguez-Martínez, M Martínez de Pancorbo, P Pastor, J Pérez-Tur.   

Abstract

BACKGROUND: Frontotemporal dementia with parkinsonism is often linked to chromosome 17 and is related to mutations in the MAPT gene. In some families the genetic basis is still unknown. The authors report two pedigrees with FTDP-17 harboring a novel mutation (K317M) in exon 11 in the MAPT gene.
METHODS: The authors identified two apparently unrelated pedigrees with an autosomal dominant neurodegenerative condition. Thirteen patients were examined and eight autopsies were performed.
RESULTS: Mean age at onset was 48 years. Mean disease duration was 6 years. Dysarthria often heralded the disease. All cases had parkinsonism and pyramidalism and half of them had amyotrophy. Behavioral or personality changes were not a prominent feature. Cognitive decline appeared late in the evolution. Neuropathologically, a massive degeneration of the substantia nigra without Lewy bodies was a constant finding. A variable degree of frontotemporal atrophy was found. Corticospinal tract degeneration and anterior horn neuron loss were present in six of seven autopsies in which the spinal cord was examined. An extensive deposition of abnormal tau protein in a mixed pattern (neuronal, glial) was observed. Pick's bodies were not seen. Biochemical analysis of tau revealed two bands of 64 and 68 kDa.
CONCLUSION: Genetic analysis revealed the same novel mutation (K317M) in exon 11 of the MAPT gene in both pedigrees. A common haplotype between members of the two pedigrees suggests that they belong to the same family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883319     DOI: 10.1212/01.WNL.0000160116.65034.12

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  An algorithm for genetic testing of frontotemporal lobar degeneration.

Authors:  J S Goldman; R Rademakers; E D Huey; A L Boxer; R Mayeux; B L Miller; B F Boeve
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

2.  Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.

Authors:  Naomi Kouri; Yari Carlomagno; Matthew Baker; Amanda M Liesinger; Richard J Caselli; Zbigniew K Wszolek; Leonard Petrucelli; Bradley F Boeve; Joseph E Parisi; Keith A Josephs; Ryan J Uitti; Owen A Ross; Neill R Graff-Radford; Michael A DeTure; Dennis W Dickson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2014-02       Impact factor: 17.088

3.  A novel tau mutation, p.K317N, causes globular glial tauopathy.

Authors:  Pawel Tacik; Michael DeTure; Wen-Lang Lin; Monica Sanchez Contreras; Aleksandra Wojtas; Kelly M Hinkle; Shinsuke Fujioka; Matthew C Baker; Ronald L Walton; Yari Carlomagno; Patricia H Brown; Audrey J Strongosky; Naomi Kouri; Melissa E Murray; Leonard Petrucelli; Keith A Josephs; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-04-22       Impact factor: 17.088

Review 4.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

5.  The evolving biology of cell reprogramming.

Authors:  Ian Wilmut; Gareth Sullivan; Ian Chambers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

6.  FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.

Authors:  Pawel Tacik; Michael A DeTure; Yari Carlomagno; Wen-Lang Lin; Melissa E Murray; Matthew C Baker; Keith A Josephs; Bradley F Boeve; Zbigniew K Wszolek; Neill R Graff-Radford; Joseph E Parisi; Leonard Petrucelli; Rosa Rademakers; Richard S Isaacson; Kenneth M Heilman; Ronald C Petersen; Dennis W Dickson; Naomi Kouri
Journal:  Brain Pathol       Date:  2016-10-05       Impact factor: 6.508

7.  Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons.

Authors:  Leo F McCluskey; Felix Geser; Lauren B Elman; Vivianna M Van Deerlin; John L Robinson; Virginia M-Y Lee; John Q Trojanowski
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-05-09       Impact factor: 4.092

8.  Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.

Authors:  Andy J Liu; Jessica E Chang; Georges Naasan; Adam L Boxer; Bruce L Miller; Salvatore Spina
Journal:  Neurocase       Date:  2020-02-23       Impact factor: 0.881

9.  Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.

Authors:  Albert Lladó; Raquel Sánchez-Valle; Maria Jesús Rey; Mario Ezquerra; Eduardo Tolosa; Isidro Ferrer; José Luis Molinuevo
Journal:  J Neurol       Date:  2008-03-25       Impact factor: 4.849

10.  Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.

Authors:  Leonel T Takada; Maria Lucia V Pimentel; Mariely Dejesus-Hernandez; Jamie C Fong; Jennifer S Yokoyama; Anna Karydas; Marie-Pierre Thibodeau; Nicola J Rutherford; Matthew C Baker; Catherine Lomen-Hoerth; Rosa Rademakers; Bruce L Miller
Journal:  Arch Neurol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.